ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,537,072, issued on Jan. 27, was assigned to Amazon Technologies Inc. (Seattle).
"Immunogenic response prediction based on major histocompatibility complex (MHC) data" was invented by Layne Christopher Price (Seattle), David Heckerman (Bellevue, Wash.) and Gil Sadeh (Herzliya, Israel).
According to the abstract* released by the U.S. Patent & Trademark Office: "Immunogenic response prediction techniques are described. In an example, a system receives first training data that identifies a peptide, a first set of multiple major histocompatibility complex (MHC) molecules, and an immunogenic response associated with the peptide and the first set. The system updates a parameter of a first m...